McCaughey Urges Use of First NYS Hospital Infection Report
NEW YORK, June 30 /PRNewswire-USNewswire/ -- Betsy McCaughey of the Committee to Reduce Infection
Deaths (RID) urges families to make use of hospital infection
rates made available by the NYS Department of Health today. "Now patients can learn which hospitals in their area have the lowest infecti...
Blue Light Destroys Antibiotic-Resistant Staph Infection - Results Reported in Photomedicine and Laser Surgery Journal
NEW ROCHELLE, N.Y., Jan. 29 /PRNewswire/ -- Two common strains of methicillin-resistant Staphylococcus aureus, commonly known as MRSA, were virtually eradicated in the laboratory by exposing them to a wavelength of blue light, in a process called photo-irradiation that is described in a paper pu...
Leading Healthcare System Decreases MRSA Infection Rate by 53 Percent - Offers Protocol & Educational Materials Free of Charge to Other Organizations
Infant Deaths Spur Hard-Hitting, System-Wide Hand Washing Campaign That Drives Culture Change, Saves Lives
CHARLOTTE, N.C., Sept. 16 /PRNewswire/ -- Novant Health, one of the top
10 integrated health systems in the country, dramatically increased
hand-washing compliance from ...
Study Findings Show Infection Control Intervention Helps Keep Kids in School
Disinfecting and using hand sanitizers helped reduce absenteeism rates
in elementary schools
BOSTON, June 2 /PRNewswire-USNewswire/ -- A study from researchers at
Children's Hospital Boston published in Pediatrics found that a simple
infection control intervention in elementary schools -- dis...
Alabama Hospitals Compare Infection Prevention Performance Statewide With New Benchmarking Tool
MedMined(TM) services from Cardinal Health Equip Hospitals to Measure Infection
Performance Against Peers to Facilitate Best Practice Identification and Sharing
DUBLIN, Ohio, April 29 /PRNewswire-FirstCall/ -- Cardinal Health, a
global provider of products and service...
New York Infection Prevention Expert Named Recipient of Carole DeMille Award
WASHINGTON, April 8, 2008 /PRNewswire-USNewswire/ -- The Association
for Professionals in Infection
Control and Epidemiology (APIC) today
announced that Rachel L. Stricof, MT, MPH, of Albany, NY, has been named
the 2008 recipient of the prestigious Carole DeMille Achievement Award.
Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin
- Response at 12 weeks is a powerful predictor of eventual treatment success -
BOSTON, Nov. 2 /PRNewswire/ -- Roche today announced final results from
the REPEAT study, which demonstrated that treatment with once-weekly
PEGASYS(R) (peginterferon alfa-2a) and dai...
'Superbug' Outbreak Calls for Immediate Increased Attention on Infection Control
NEW YORK, Oct. 31 /PRNewswire/ -- A recent outbreak of MRSA
(Methicillin- resistant Staphylococcus aureus) bacteria, often referred to
as "the superbug," should cause organizations and facilities nationwide to
reevaluate and redouble their infection
control efforts. The superbug is resistant ...
Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
New Family of Antibacterial Products aimed at reducing cross contamination infections including MRSA
JACKSONVILLE, Fla., Oct. 18 /PRNewswire/ -- Seal Shield Corporation
announced today the SILVER SEAL(TM) family of antibacterial products for
infection control. Notably, Sea...
Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
Positive data from subgroup analysis presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting in Helsinki , Finland
SAN DIEGO, May 17 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) announced that the results fr...
NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection
EMERYVILLE, Calif., March 7 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Alternext: NBY), a mid-stage biopharmaceutical company developing first-in-class, novel, synthetic anti-infective products for the treatment and prevention of a wide range of bacterial, fungal, and viral infe...
Early Switch from IV to Oral Meds Is Effective for Children with Acute Bone Infection
PHILADELPHIA, Feb. 12 /PRNewswire-USNewswire/ -- When treating children for acute osteomyelitis--a bacterial bone infection--an early changeover from intravenous (IV) antibiotic delivery to oral antibiotics is just as effective as continuing the IV therapy, according to pediatric researchers.
British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection
University of Nottingham Scientists Leading Major Study into Lethal 'Super' Strains of C.difficile
CHICAGO, Jan. 28 /PRNewswire/ -- The British Midlands Development Corporation today announced that scientists at The University of Nottingham are leading a major European study to unravel the ...
Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
CE IVD Menu Expanded to Eight On-Demand Tests for Use on the GeneXpert(R) System
SUNNYVALE, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today announced the release of Xpert(TM) vanA/vanB as a European CE
IVD Mark product under the European Dir...
Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
VIENNA, Austria, Aug. 28 /PRNewswire/ -- Intercell AG (VSE: ICLL) today
announced that its collaborator Merck & Co., Inc. has initiated a Phase II
clinical trial of V710, an investigational vaccine for the prevention of
Staphylococcus aureus (S. aureus) infections. This randomized double blind...
Nationwide Progress Poll Reveals Increased Efforts by Hospitals to Control MRSA Infection
Healthcare Facility Infection
Prevention and Control Professionals Cite
Greatest Needs for Continued Success to Combat MRSA Including Additional
Staff, More Environmental Services and Time-Saving High Tech Solutions
DENVER, June 17 /PRNewswire-USNewswire/ -- More than three out of four
NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection
HELSINGBORG, Sweden, April 15 /PRNewswire/ -- NOLabs AB, the Swedish
medtech company focusing on developing innovative Nitric Oxide-containing
medical devices, today reported that it has achieved another important
milestone in the development of a new preventive therapy against urinary
MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection
Combined data from two Phase 3 trials show clinical success rates statistically equivalent to oral antibiotic therapy
WELLESLEY HILLS, Mass., March 13 /PRNewswire-FirstCall/ -- MacroChem
Corporation (OTC Bulletin Board: MACM) announced today the presentation of
a poster entitled "T...
OPKO Health and Pathogenics Announce Data Publication Demonstrating the Potential Utility of NCT in a Severe Eye Infection
-In Vitro Data Shows OPKO's Formulation of NCT Has Promising Activity Against Acanthamoeba Keratitis, a Serious Ocular Infection- -Provides Additional Evidence That This Phase II Agent Has Good
Tolerability and Broad Anti-Microbial Activity Against a Wide Range of ...
Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
ANA598 demonstrates significant antiviral activity in vivo
SAN DIEGO, Jan. 3 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals,
Inc. (Nasdaq: ANDS ) announced preliminary data today from two studies of
ANA598, a non-nucleoside inhibitor of the hepatitis C virus (HCV) NS5B
European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
- Product Developed Through Joint Venture Between Bristol-Myers Squibb and Gilead Sciences, the First of Its Kind in HIV Treatment -
PRINCETON, N.J. and FOSTER CITY, Calif., Dec. 17 /PRNewswire-FirstCall/
-- The European Commission has granted marketing authorization for
Chimerix Initiates a Multi-dose Clinical Trial of the Company's Lead Compound, CMX001, for the Treatment for Smallpox Infection
RESEARCH TRIANGLE PARK, N.C., Dec. 11 /PRNewswire/ -- Chimerix, Inc., a
biotechnology company developing orally available antiviral therapeutics,
announced today that the Company has initiated a multi-dose trial with its
lead drug candidate, CMX001, an oral treatment for smallpox infection. Th...
NTMir Announces Research Grants for Epidemiology and Household Water as Source of Infection
CORAL GABLES, Fla., Nov. 9 /PRNewswire/ -- NTM Info & Research (NTMir),
a not-for-profit organization that supports education and research for
nontuberculous mycobacterial (NTM) lung disease announces the
implementation of Rapid Information Pilot Studies (RIPS(TM)), an innovative
program to pr...
R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
PRINCETON, N.J., Oct. 24 /PRNewswire-FirstCall/ -- Pharmasset, Inc.
(Nasdaq: VRUS ) has received fast track designation from the U.S. Food and
Drug Administration (FDA) for R7128 for the treatment of chronic hepatitis
C virus (HCV) infection. R7128 is a prodrug of PSI-6130, an oral cytidine
The American Liver Foundation Urges Cautious Optimism about CDC
Report on Declining Acute Hepatitis Infection Rates
Focus Must Remain on the Millions Still Suffering from Chronic
Hepatitis B and C
NEW YORK, March 21, 2007 /PRNewswire/ -- The Centers for Disease
Control and Prevention (CDC) has reported that significant decline
in the rates of new acute hepatitis infections in the United States
in the last 10 ye...
Alnylam Reports Results of Human Experimental Infection Model with
Respiratory Syncytial Virus
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 7, 2007 - Alnylam
Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics
company, presented data from its experimental infection
the 2007 Pediatric Academic Societies' (PAS) Annual Meeting being
held in Toronto. This study represents an imp...
Viral Enzyme Recruited in Fight Against Ear Infection
St. Jude Study Success in Using Virus Enzyme to Treat Mouse Model
of Acute Otitis Media Suggests that Nasal Spray Could Be Used to
Prevent Both Ear Infection
and Pneumonia in People with Influenza
MEMPHIS, Tenn., March 22, 2007 /PRNewswire/ -- Parents might one
day give their children a weekly tre...
Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic
Effect in New Primate Model of Established Anthrax Infection
Pilot Study Demonstrates 50% Survival in Valortim-Treated Animals
PRINCETON, N.J. and ANNAPOLIS, Md., March 29, 2007
/PRNewswire-FirstCall/ -- Medarex, Inc. , a leading monoclonal
antibody company, and PharmAthene, Inc., a privately held
biotechnology company dedicated to the development...
Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic
Effect in New Primate Model of Established Anthrax Infection
Pilot Study Demonstrates 50% Survival in Valortim-Treated
PRINCETON, N.J. and ANNAPOLIS, MD., March 29, 2007 - Medarex,
Inc. (Nasdaq: MEDX), a leading monoclonal antibody company, and
PharmAthene, Inc., a privately held biotechnology company dedicated
to the development of biodefense cou...
Peramivir Protects Mice From Lethal H5N1 Infection
St. Jude study shows intramuscular injection of peramivir for eight
days protected mice from lethal H5N1 influenza virus infection
inhibited virus replication, supporting the use of this drug to
control influenza during a pandemic
MEMPHIS, Tenn., May 01, 2007 /PRNewswire-USNewswire/ -- The
St. Jude Study Shows Effectiveness of Peramivir in Prevention of
Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection
BioCryst Says Study Confirms and Extends Evidence Seen in a
BIRMINGHAM, Ala., May 02, 2007 /PRNewswire-FirstCall/ --
BioCryst Pharmaceuticals, Inc. today announced that investigators
at St. Jude Children's Research Hospital, Memphis, TN, reported
favorable results evaluating peramiv...
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic
Drug to Treat Viral Eye Infection
TAMPA, Fla., April 16, 2007 /PRNewswire/ -- Sirion Therapeutics,
Inc., an ophthalmic-focused biopharmaceutical company, announced
today that it has received orphan drug designation from the Food
and Drug Administration (FDA) for its anti-viral therapy,
ganciclovir, for the treatment of acute herpe...
Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,
Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for
Clinical Development in Chronic Hepatitis C Virus Infection
SAN DIEGO, June 20, 2007 /PRNewswire-FirstCall/ -- Anadys
Pharmaceuticals, Inc. , a biopharmaceutical company committed to
the discovery, development and commercialization of novel medicines
for the treatment of hepatitis and cancer, announced today that it
has nominated ANA598 as a candidate for ...
OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer
...mg/m2 of pemetrexed. None of the patients in cohort one had an initial dose-limiting toxicity (IDLT) with two cycles of therapy. There was one IDLT of infection
with neutropenia in cohort two. Aside from grade 3 fatigue in two patients, there were no grade 3 or greater nonhematologic toxicities. A median of 4....
Pennsylvania Agriculture Department Issues Quarantine for Allegheny County Horse Stable
...iculture Secretary Dennis Wolff said today.
There is no threat to human health from EHV-1.
"Equine Herpesvirus causes upper respiratory infection
and can cause severe neurological disease in horses," said Wolff. "The quarantine was put in place to restrict the movement of horses from the stable ...
Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
...reactions, facial swelling, hives, and throat tightness reported.
Patients who use inhaled steroid medicines for asthma may develop a fungal infection
of the mouth and throat. Rinse your mouth after using ASMANEX.
It is possible that hypercorticism (an excess level of steroids in your body) ...
Northern California Cancer Center's First-of-Its-Kind Research Reveals Low Socioeconomic Status Often Equals Poor Chance of Lymphoma Survival
...ma, is a cancer of the immune system and white blood cells which affects men and women equally. The cancer involves the body's lymph nodes which fight infection
and disease. It begins with an enlargement of the lymph nodes and symptoms can include fever, weight loss, sweating and fatigue. It is called "foll...
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
... patients on belimumab. The most common adverse events were
headache, arthralgia, upper respiratory tract infections, urinary
and influenza, and were also comparable between
belimumab and placebo treatment groups. No malignancies were
Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks
.... The newly granted
second designation relates to pulmonary infections caused by Burkholderia
cepacia (B. cepacia) pathogens.
Despite stringent infection
control practices, B. cepacia infections
still occur in cystic fibrosis patients and can lead to fatal sepsis. The
cell envelopes of these especially ...
Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV
...iroc. These infections and other adverse events observed in these patients were generally consistent with expectations for patients with advanced HIV infection
and with the multiple drugs being administered.(8)
Schering-Plough is an innovation-driven, science-cent...